By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.
Mark Leonard
Advertisement
Mark Leonard is the director in the cell and molecular sciences group in the department of Drug Substance Development at Wyeth Biopharma
Articles by Mark Leonard
Advertisement
Latest Updated Articles
Advertisement
Advertisement